Nebenwirkungen · NutropinAq
NutropinAq 10 mg/2 ml (30 IU) solution for injection. · Abschnitt 4.8 · PDF-Seite 6
HOS-091383 · Präparat HOS-084303
The adverse reactions reported in both adults and children receiving Nutropin, NutropinAq, Nutropin Depot or Protropin (somatrem) are listed in the table below, based on experience from clinical trials all approved indications (642 patients) and post-marketing sources which included a surveillance survey (National Cooperative Growth Study [NCGS] in 35,344 patients). Approximately 2.5 % of patients from the NCGS have experienced drug related adverse reactions.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-07-20T14:29:00Z · SHA-256 e5bd062c361eb50bec364b174f269b43c7017d76fb675397b49680f729d1cb9a · Passage 57e2cd73a48edfc3ce36f0720840ac73142d2fb40939e31e28cedae6e967fa4a · Zeichen 31–494 im Abschnitt